Andrianto
Overview
Explore the profile of Andrianto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suryawan I, Andrianto , Agita A, Ratri A, Nugraha R
Glob Cardiol Sci Pract
. 2025 Feb;
2024(5):e202446.
PMID: 39931451
Treating irreversible cardiomyocyte loss following myocardial infarction presents several therapeutic challenges. While cell therapy shows promise as a regenerative treatment for infarcted cardiac tissue, different cell sources vary in their...
2.
Andrianto , Albab C, Mahardika N
Tzu Chi Med J
. 2024 Oct;
36(4):387-395.
PMID: 39421491
Cardiovascular diseases (CVDs) are major contributors to illness and death globally. Body mass index (BMI) is a well-established prognostic factor on cardiovascular risk outcome. Numerous investigations have provided evidence for...
3.
Muharram F, Multazam C, Mustofa A, Socha W, Andrianto , Martini S, et al.
J Epidemiol Glob Health
. 2024 Aug;
14(3):1369.
PMID: 39102160
No abstract available.
4.
Muharram F, Multazam C, Mustofa A, Socha W, Andrianto , Martini S, et al.
J Epidemiol Glob Health
. 2024 Feb;
14(1):193-212.
PMID: 38324147
Importance: Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity. Compared with disease burden rates in 1990, significant reductions in Disability-Adjusted Life Years (DALYs) burden rates for CVD...
5.
Andrianto , Puspitasari M, Ardiana M, Dewi I, Shonafi K, Wardhani L, et al.
Ther Adv Cardiovasc Dis
. 2022 Oct;
16:17539447221132367.
PMID: 36314075
Background: Atherosclerosis is a condition in which the medium to large arteries become inflamed over time. The cornerstone to the atherosclerosis process is endothelial dysfunction. Simvastatin is a cholesterol-lowering drug...
6.
Andrianto , Pikir B, Suryawan I, Hermawan H, Harsoyo P
J Stem Cells Regen Med
. 2022 Aug;
18(1):21-26.
PMID: 36003658
Coronary heart disease (CHD) is a leading cause of death globally, while its current management is limited to reducing the myocardial infarction area without actually replacing dead cardiomyocytes. Direct cell...
7.
Suryawan I, Andrianto , Anggaraeni A, Agita A, Nugraha R
Cardiovasc Hematol Agents Med Chem
. 2022 May;
21(3):156-166.
PMID: 35538825
Background: Several studies have shown that adipose-derived mesenchymal stem cells (AMSCs) can differentiate into mesenchymal lineages, including cardiac cell types, but complete differentiation into cardiomyocytes is challenging. Unfortunately, the optimal...
8.
Andrianto , Pikir B, Ferdiansyah , Pristianto T, Hermawan H, Zaini B, et al.
Cell Reprogram
. 2022 Jan;
24(1):21-25.
PMID: 35073164
The development of a direct reprogramming method to provide cell availability for regenerative therapy has led to a lot of studies. However, the search for appropriate cell sources and methods...
9.
Andrianto , Al-Farabi M, Nugraha R, Marsudi B, Azmi Y
Microvasc Res
. 2021 Jul;
138:104224.
PMID: 34273359
Background: Several studies have reported that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can directly infect endothelial cells, and endothelial dysfunction is often found in severe cases of coronavirus...